Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
A Reboxetine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Reboxetine Mesylate, including repackagers and relabelers. The FDA regulates Reboxetine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Reboxetine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Reboxetine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Reboxetine Mesylate supplier is an individual or a company that provides Reboxetine Mesylate active pharmaceutical ingredient (API) or Reboxetine Mesylate finished formulations upon request. The Reboxetine Mesylate suppliers may include Reboxetine Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Reboxetine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Reboxetine Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Reboxetine Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Reboxetine Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Reboxetine Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Reboxetine Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Reboxetine Mesylate suppliers with NDC on PharmaCompass.
Reboxetine Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Reboxetine Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Reboxetine Mesylate GMP manufacturer or Reboxetine Mesylate GMP API supplier for your needs.
A Reboxetine Mesylate CoA (Certificate of Analysis) is a formal document that attests to Reboxetine Mesylate's compliance with Reboxetine Mesylate specifications and serves as a tool for batch-level quality control.
Reboxetine Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Reboxetine Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Reboxetine Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Reboxetine Mesylate EP), Reboxetine Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Reboxetine Mesylate USP).
LOOKING FOR A SUPPLIER?
